Differential effects of norUDCA and UDCA in obstructive cholestasis in mice (Q40606268)

22 September 2017

Differential effects of norUDCA and UDCA in obstructive cholestasis in mice (English)

1 reference

22 September 2017

9

1 reference

22 September 2017

Tarek Moustafa

4

0 references

Peter Fickert

object named as

Peter Fickert

1

0 references

Michael Trauner

11

object named as

Michael Trauner

1 reference

22 September 2017

3

Dagmar Silbert

1 reference

22 September 2017

5

Emina Halilbasic

1 reference

22 September 2017

6

Elisabeth Krones

1 reference

22 September 2017

2

Marion J Pollheimer

1 reference

22 September 2017

10

Helmut Denk

1 reference

22 September 2017

Franziska Durchschein

7

1 reference

PMCID

3650580

22 September 2017

Andrea Thüringer

8

1 reference

22 September 2017

29 January 2013

1 reference

22 September 2017

Journal of Hepatology

1 reference

22 September 2017

58

1 reference

22 September 2017

6

1 reference

22 September 2017

1201-1208

1 reference

The autoimmunity of primary biliary cirrhosis and the clonal selection theory

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Pathogenesis of cholestatic liver disease and therapeutic approaches

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Primary biliary cirrhosis: a 2010 update

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Murine models of autoimmune cholangitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Bile acids: trying to understand their chemistry and biology with the hope of helping patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Current diagnosis and management of primary sclerosing cholangitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Sclerosing cholangitis: a focus on secondary causes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Animal models for primary sclerosing cholangitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Orthotopic liver transplantation for cholestatic diseases.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Pharmacotherapy of cholestatic liver diseases

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Transplantation trends in primary biliary cirrhosis.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650580

Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients

20 August 2018

1 reference

12 December 2020

Synthesis of 24-nor-5 beta-cholan-23-oic acid derivatives: a convenient and efficient one-carbon degradation of the side chain of natural bile acids

1 reference

12 December 2020

Primary biliary cirrhosis

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit

1 reference

12 December 2020

10.1016/J.JHEP.2013.01.026

Identifiers

DOI

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

PMCID

3650580